-

01:09:58 PM

NUMIF Stock News

NUMIF - Numinus Wellness Inc.

09/25/23 7:16 PM

OTC : NUMIF

Numinus Wellness Inc. Announces At-The-Market Offering Equity Program

VANCOUVER, BC, Sept. 25, 2023/ PRNewswire/- Numinus Wellness Inc., is pleased to announce that it has established an at-the-market equity offering program that allows the Company to issue and sell up to C $10,000,000 of common shares in the capital of the Company from time to time, at the Company's discretion and subject to regulatory requirements.

RHEA-AI

neutral

09/19/23 7:00 AM

OTC : NUMIF

clinical trial

Numinus Congratulates MAPS on its Phase 3 Study Results Published in Nature Medicine

Study Results are widely regarded as the final step before MDMA-assisted therapy is reviewed by the FDA for wider patient access. Numinus continues to support greater access to these important therapies, through its growing psychedelic-assisted therapy practitioner training programs. VANCOUVER, BC, Sept. 19, 2023/ PRNewswire/- Numinus Wellness Inc., a...

RHEA-AI

neutral

09/18/23 6:45 PM

OTC : NUMIF

Numinus Takes Actions to Accelerate its Path to Profitability by Focusing on Positive Cash Flow Generating Operations

The Company is ceasing operating activities at Numinus Bioscience– its non-revenue producing research lab, and is consolidating clinic operations in certain regions to enhance company performance and improve the overall client experience. Collectively, these activities are expected to save nearly C $1 million of annualized cash expenses, which will...

RHEA-AI

positive

08/09/23 7:00 AM

OTC : NUMIF

conferences

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023

VANCOUVER, BC, Aug. 9, 2023/ PRNewswire/- Numinus Wellness Inc.– a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Nikhil Handa, CFO, will participate in a Water Tower Research Fireside Chat on Thursday, August 17, 2023, at 11:00 a.m. ET/ 8:00 a.m. PT.

RHEA-AI

neutral

07/17/23 4:01 PM

OTC : NUMIF

earnings

Numinus Wellness Inc. Reports Q3 2023 Results

Q3 2023 revenues grew 713.3% year-over-year to $6.0 million Q3 2023 revenues grew 12.6% from previous quarter Gross profit of $2.1 million, increased 1051.6% year-over-year Staff reductions and operational realignment resulted in $0.6 million of one-time expenses during the quarter Cash position of $13.0 million as at May 31, 2023 Activities taken...

RHEA-AI

positive

07/10/23 6:29 PM

OTC : NUMIF

conferences

Numinus to Present at the Small Cap Growth Virtual Investor Conference on July 13, 2023

VANCOUVER, BC, July 10, 2023/ PRNewswire/- Numinus Wellness Inc.– a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO, will present live at the Small Cap Growth 50 Virtual Investor Conference, hosted by VirtualInvestorConferences.com, on...

RHEA-AI

neutral

06/29/23 7:00 AM

OTC : NUMIF

conferencesearnings

Numinus to Host Q3 2023 Results Conference Call on July 17, 2023

VANCOUVER, BC, June 29, 2023/ PRNewswire/- Numinus Wellness Inc., a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its financial results for the quarter ended May 31, 2023, after market close on Monday, July 17, 2023.. Interested parties are invited to participate in the...

RHEA-AI

neutral

06/22/23 7:00 AM

OTC : NUMIF

Numinus Announces Agreement with HealingMaps to Drive Strategic Clinic Growth

VANCOUVER, BC, June 22, 2023/ PRNewswire/- Numinus Wellness Inc.– a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, is pleased to announce that it has signed an agreement with HealingMaps– a source for individuals looking for accurate and honest information about psychedelic-assisted...

RHEA-AI

very positive

06/15/23 7:00 AM

OTC : NUMIF

partnership

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

Numinus has submitted a Clinical Trial Application to Health Canada to enable MDMA-assisted therapy Experiential Opportunities for practitioners as part of an investigational Phase 1 clinical trial. If approved, Numinus intends to make the Experiential Opportunity available to practitioners as part of its psychedelic-assisted therapy education...

RHEA-AI

very positive

06/14/23 7:00 AM

OTC : NUMIF

management

Numinus Appoints New Chief Financial Officer

VANCOUVER, BC, June 14, 2023/ PRNewswire/- Numinus Wellness Inc., a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced the appointment of Nikhil Handa as Chief Financial Officer, effective June 15, 2023, following a thorough executive search. Current Chief Financial Officer,...

RHEA-AI

neutral

1 2 3 4 5 6 7 8 Next